6EIC image
Deposition Date 2017-09-19
Release Date 2018-06-27
Last Version Date 2024-06-19
Entry Detail
PDB ID:
6EIC
Keywords:
Title:
Crystal structure of Rv0183, a Monoglyceride Lipase from Mycobacterium Tuberculosis
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 31 1 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Mycobacterium Tuberculosis Monoglyceride Lipase
Gene (Uniprot):Rv0183
Chain IDs:A (auth: C), B (auth: A), C (auth: B)
Chain Length:279
Number of Molecules:3
Biological Source:Mycobacterium tuberculosis H37Rv
Primary Citation
The crystal structure of monoacylglycerol lipase from M. tuberculosis reveals the basis for specific inhibition.
Sci Rep 8 8948 8948 (2018)
PMID: 29895832 DOI: 10.1038/s41598-018-27051-7

Abstact

Monoacylglycerol lipases (MGLs) are enzymes that hydrolyze monoacylglycerol into a free fatty acid and glycerol. Fatty acids can be used for triacylglycerol synthesis, as energy source, as building blocks for energy storage, and as precursor for membrane phospholipids. In Mycobacterium tuberculosis, fatty acids also serve as precursor for polyketide lipids like mycolic acids, major components of the cellular envelope associated to resistance for drug. We present the crystal structure of the MGL Rv0183 from Mycobacterium tuberculosis (mtbMGL) in open conformation. The structure reveals remarkable similarities with MGL from humans (hMGL) in both, the cap region and the α/β core. Nevertheless, mtbMGL could not be inhibited with JZL-184, a known inhibitor of hMGL. Docking studies provide an explanation why the activity of mtbMGL was not affected by the inhibitor. Our findings suggest that specific inhibition of mtbMGL from Mycobacterium tuberculosis, one of the oldest recognized pathogens, is possible without influencing hMGL.

Legend

Protein

Chemical

Disease

Primary Citation of related structures